Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15871059 | 0.95 | CHRM2 (0.53) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL20863104 | 0.94 | CHRM2 (0.52) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL21208732 | 0.91 | NOTUM (0.46) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL13534711 | 0.88 | ALDH1A1 (0.51) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL12956755 | 0.84 | ALDH1A1 (0.59) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL21991681 | 0.84 | MAPT (0.51) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL5905885 | 0.83 | CHRM2 (0.56) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL4103062 | 0.83 | CHRM1 (0.48) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL16479227 | 0.81 | ALDH1A1 (0.49) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL25818515 | 0.81 | ALDH1A1 (0.54) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481659-B2 | Cure accelerators for anaerobic curable compositions | HENKEL CORPORATION (US) | 2013-07-09 | — | — | US | disclosed |
| US-8481659-B2 | Cure accelerators for anaerobic curable compositions | HENKEL CORPORATION (US) | 2013-07-09 | — | — | US | disclosed |
| US-20120157641-A1 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | LOCTITE (R&D) LIMITED (IE) | 2012-06-21 | — | — | US | disclosed |
| US-20120157641-A1 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | LOCTITE (R&D) LIMITED (IE) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157641-A1 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | AHCY, AHCYL1, DNMT3L | CHRM2 3292/4885CHRM4 3571/4885CHRM1 3209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.